Natural killer (NK) cells are effector lymphocytes with pivotal roles in the resistance against various tumors; dysfunction of NK cells often results in advanced tumor progression. Tumors develop in three stages comprising initiation, promotion, and progression, but little is known about the interrelationships between NK cells and tumor cells at different stages of tumor development. Here, we demonstrated that NK cells prevented tumor initiation potently but did not prevent tumor promotion or tumor progression in Kras-driven lung cancer. Moreover, loss of the antitumor effect in NK cells was closely associated with their dysfunctional state during tumor promotion and progression. Mechanistically, aberrant fructose-1,6-bisphosphatase (FBP1) expression in NK cells elicited their dysfunction by inhibiting glycolysis and impairing viability. Thus, our results show dynamic alterations of NK cells during tumor development and uncover a novel mechanism involved in NK cell dysfunction, suggesting potential directions for NK cell-based cancer immunotherapy involving FBP1 targeting.
Pubmed ID: 30033198 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets IgG (H+L)
View all literature mentionsThis polyclonal targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets beta Tubulin
View all literature mentionsThis monoclonal targets CD253 (TRAIL)
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets CD366
View all literature mentionsThis monoclonal targets Perforin
View all literature mentionsThis monoclonal targets CD274
View all literature mentionsThis monoclonal targets CD279 (PD-1)
View all literature mentionsThis monoclonal targets CD335
View all literature mentionsThis monoclonal targets CD335 (NKp46)
View all literature mentionsThis monoclonal targets CD314 (NKG2D)
View all literature mentionsThis monoclonal targets Mouse NKG2AB6
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets Mouse Granzyme B PE 25 ug
View all literature mentionsThis monoclonal targets Ly-6G Ly-6C
View all literature mentionsThis monoclonal targets Mouse/Rat Foxp3 Alexa Fluor® 647 25 ug
View all literature mentionsThis monoclonal targets FBP1 antibody [EPR4620]
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD152 (CTLA-4)
View all literature mentionsThis monoclonal targets CD96
View all literature mentionsThis monoclonal targets CD94
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets Mouse CD49b
View all literature mentionsThis monoclonal targets CD49a
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets Mouse CD44
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD276 (B7-H3)
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD226
View all literature mentionsThis monoclonal targets CD16/CD32
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD122 (IL-2 Receptor β)
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD107a (LAMP-1)
View all literature mentionsStatistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentions